1220 related articles for article (PubMed ID: 15705806)
21. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
22. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane.
Funakoshi T; Yanai A; Shinoda K; Kawano MM; Mizukami Y
Biochem Biophys Res Commun; 2006 Aug; 346(3):904-10. PubMed ID: 16780796
[TBL] [Abstract][Full Text] [Related]
23. GPER1/GPR30 in the brain: Crosstalk with classical estrogen receptors and implications for behavior.
Hadjimarkou MM; Vasudevan N
J Steroid Biochem Mol Biol; 2018 Feb; 176():57-64. PubMed ID: 28465157
[TBL] [Abstract][Full Text] [Related]
24. The unfolding stories of GPR30, a new membrane-bound estrogen receptor.
Maggiolini M; Picard D
J Endocrinol; 2010 Feb; 204(2):105-14. PubMed ID: 19767412
[TBL] [Abstract][Full Text] [Related]
25. Role of G-protein-coupled estrogen receptor (GPER/GPR30) in maintenance of meiotic arrest in fish oocytes.
Thomas P
J Steroid Biochem Mol Biol; 2017 Mar; 167():153-161. PubMed ID: 28007532
[TBL] [Abstract][Full Text] [Related]
26. G protein-coupled receptor 30 mediates estrogen-induced proliferation of primordial germ cells via EGFR/Akt/β-catenin signaling pathway.
Ge C; Yu M; Zhang C
Endocrinology; 2012 Jul; 153(7):3504-16. PubMed ID: 22635679
[TBL] [Abstract][Full Text] [Related]
27. Detection of the Phosphorylation of the Estrogen Receptor α as an Outcome of GPR30 Activation.
Clark S; Pollard K; Rainville J; Vasudevan N
Methods Mol Biol; 2016; 1366():457-470. PubMed ID: 26585157
[TBL] [Abstract][Full Text] [Related]
28. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.
Madeo A; Maggiolini M
Cancer Res; 2010 Jul; 70(14):6036-46. PubMed ID: 20551055
[TBL] [Abstract][Full Text] [Related]
29. Expression and function of the nonclassical estrogen receptor, GPR30, in human cartilage and chondrocytes.
Ribeiro M; Sousa C; Rufino AT; Judas F; Mendes AF
J Cell Physiol; 2020 Nov; 235(11):8486-8494. PubMed ID: 32324271
[TBL] [Abstract][Full Text] [Related]
30. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
31. Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2.
He YY; Du GQ; Cai B; Yan Q; Zhou L; Chen XY; Lu W; Yang YX; Wan XP
J Cancer Res Clin Oncol; 2012 May; 138(5):775-83. PubMed ID: 22270964
[TBL] [Abstract][Full Text] [Related]
32. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30.
Carnesecchi J; Malbouyres M; de Mets R; Balland M; Beauchef G; Vié K; Chamot C; Lionnet C; Ruggiero F; Vanacker JM
PLoS One; 2015; 10(3):e0120672. PubMed ID: 25781607
[TBL] [Abstract][Full Text] [Related]
33. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
34. G protein-coupled receptor 30 down-regulates cofactor expression and interferes with the transcriptional activity of glucocorticoid.
Ylikomi T; Vienonen A; Ahola TM
Eur J Biochem; 2004 Nov; 271(21):4159-68. PubMed ID: 15511221
[TBL] [Abstract][Full Text] [Related]
35. Role of ERα36 in membrane-associated signaling by estrogen.
Chaudhri RA; Schwartz N; Elbaradie K; Schwartz Z; Boyan BD
Steroids; 2014 Mar; 81():74-80. PubMed ID: 24252378
[TBL] [Abstract][Full Text] [Related]
36. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
Manavathi B; Kumar R
J Cell Physiol; 2006 Jun; 207(3):594-604. PubMed ID: 16270355
[TBL] [Abstract][Full Text] [Related]
37. In vivo effects of a GPR30 antagonist.
Dennis MK; Burai R; Ramesh C; Petrie WK; Alcon SN; Nayak TK; Bologa CG; Leitao A; Brailoiu E; Deliu E; Dun NJ; Sklar LA; Hathaway HJ; Arterburn JB; Oprea TI; Prossnitz ER
Nat Chem Biol; 2009 Jun; 5(6):421-7. PubMed ID: 19430488
[TBL] [Abstract][Full Text] [Related]
38. G protein-coupled receptor 30 in tumor development.
Wang D; Hu L; Zhang G; Zhang L; Chen C
Endocrine; 2010 Aug; 38(1):29-37. PubMed ID: 20960099
[TBL] [Abstract][Full Text] [Related]
39. G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium.
Maiti K; Paul JW; Read M; Chan EC; Riley SC; Nahar P; Smith R
Endocrinology; 2011 Jun; 152(6):2448-55. PubMed ID: 21427217
[TBL] [Abstract][Full Text] [Related]
40. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
